Grand Capital buys 50.46% of Irbit pharmaceutical plant
Grand Capital, a pharmaceutical holding, acquired 50.46% of Irbit chemical pharmaceutical plant’s common stock. The company did not use to own any of Irbit plant’s shares before.
 | Код для вставки в блог |  | Подписаться на рассылку |  | Распечатать |